7575: Japan Lifeline Co., Ltd. - Summary | Jitta

Japan Lifeline Co., Ltd.

TYO:7575

Price
¥1,260.00
Loss Chance
44.0%
5.68JITTA SCORE
21.98%Under Jitta Line
Jitta Ranking
17 / 185
452 / 3,514
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (56)
Recent Business Performance (50)
Financial Strength (82)
Return to Shareholders (51)
Competitive Advantage (55)
Jitta Signs
Revenue and EarningConsistent
Operating MarginExpansion
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
Share RepurchaseEvery Year
CapExVery Low
Interest Coverage RatioVery Good
Recent Business PerformanceEarning decline 0.13% in the last year
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.68
21.98%
4.37
447.26%
Health Care Equipment
7.63
21.26%
3.06
55.52%
5.09
13.11%
COMPANY DESCRIPTION
Japan Lifeline Co., Ltd., a medical device company, engages in manufacturing and sale of medical device in Japan. The company’s cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, disposable ECG recorder, and venous vascular closure system. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems. In addition, the company offers gastrointestinal intervention products, including cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems; structural heart disease intervention products, such as radiofrequency wires and atrial septal defect closure devices; and aspiration catheter neurovascular intervention product. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.